{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:38:39Z","timestamp":1792024719160,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.drugalcdep.2006.07.004","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T22:15:54Z","timestamp":1156544154000},"page":"20-29","source":"Crossref","is-referenced-by-count":185,"title":["Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo"],"prefix":"10.1016","volume":"87","author":[{"given":"Frances R.","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Garawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2006.07.004_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA, American Psychiatric Association (APA)","year":"1994"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib2","article-title":"A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder","author":"Biederman","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/070674370304800806","article-title":"The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder","volume":"48","author":"Bouffard","year":"2003","journal-title":"Can. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2006.07.004_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.ALC.0000156129.98265.57","article-title":"Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder","volume":"29","author":"Brady","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-440X(93)90050-E","article-title":"History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers","volume":"34","author":"Carroll","year":"1993","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1994.03950030013002","article-title":"Psychotherapy and pharmacotherapy for ambulatory cocaine abusers","volume":"51","author":"Carroll","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ps.51.2.169","article-title":"Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults","volume":"51","author":"Castaneda","year":"2000","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1081\/ADA-100101871","article-title":"Attention-deficit\/hyperactivity disorder and substance use: symptom pattern and drug choice","volume":"25","author":"Clure","year":"1999","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.drugalcdep.2006.07.004_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2005.09.003","article-title":"Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD","volume":"82","author":"Collins","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archpsyc.56.6.493","article-title":"Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study","volume":"56","author":"Crits-Christoph","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.drugalcdep.2006.07.004_bib12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1530-0277.1996.tb01142.x","article-title":"Assessment of medication complaicne in alcoholics through UV light detection of a riboflavin tracer","volume":"20","author":"Del Boca","year":"1996","journal-title":"Alcoholism: Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1176\/appi.neuropsych.14.3.289","article-title":"A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit\/hyperactivity disorder: preliminary findings","volume":"14","author":"Dorrego","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2006.07.004_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1360-0443.2005.00986.x","article-title":"Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence","volume":"100","author":"Elkashef","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib15","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I\/P, Verision 2.0)","author":"First","year":"1995"},{"issue":"2","key":"10.1016\/j.drugalcdep.2006.07.004_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00004583-199203000-00008","article-title":"Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder","volume":"31","author":"Fitzpatrick","year":"1992","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials","volume":"29","author":"Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","article-title":"Replacement medication for cocaine dependence: methylphenidate","volume":"17","author":"Grabowski","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib20","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib21","unstructured":"Hien, D., Matzner, F., First, M., Spitzer, R., William, J., 1994. The Structured Clinical Interview for DSM-IV, Childhood version (KID-SCI), Unpublished document."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1176\/ajp.140.6.784","article-title":"An extreme case of cocaine dependence and marked improvement with methylphenidate treatment","volume":"140","author":"Khantzian","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0740-5472(84)90033-3","article-title":"Methylphenidate (Ritalin) treatment of cocaine dependence\u2014a preliminary report","volume":"1","author":"Khantzian","year":"1984","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00005053-199908000-00005","article-title":"Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment","volume":"187","author":"King","year":"1999","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1017\/S0033291703001776","article-title":"Efficacy and safety of methylphenidate in 45 adults with attention-deficit\/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial","volume":"34","author":"Kooij","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugalcdep.2005.06.012","article-title":"Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo","volume":"81","author":"Levin","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0376-8716(98)00049-0","article-title":"Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment","volume":"52","author":"Levin","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4088\/JCP.v59n0605","article-title":"Methylphenidate treatment for cocaine abusers with adult attention-deficit\/hyperactivity disorder: a pilot study","volume":"59","author":"Levin","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib29","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.addbeh.2004.03.041","article-title":"Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community","volume":"29","author":"Levin","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3109\/10826088709027454","article-title":"The validity of methadone clients\u2019 self-reported drug use","volume":"22","author":"Magura","year":"1987","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1592\/phco.23.12.1281.32697","article-title":"Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations","volume":"23","author":"Markowitz","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2005.03.026","article-title":"Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial","volume":"80","author":"McDowell","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/108705479600100303","article-title":"Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications of clinical diagnosis","volume":"1","author":"Murphy","year":"1996","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/j.1440-1614.1999.00590.x","article-title":"A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder","volume":"33","author":"Paterson","year":"1999","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.86.2.226","article-title":"Relative efficacy of long-acting stimulants on ADHD children: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline","volume":"86","author":"Pelham","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00004714-200104000-00005","article-title":"Double-blind clinical trial of sertraline treatment for alcohol dependence","volume":"21","author":"Pettinati","year":"2001","journal-title":"J. Clin. Pscyhopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib37","first-page":"253","article-title":"Use of quantitative urinalysis in monitoring cocaine use","volume":"175","author":"Preston","year":"1997","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00004583-200404000-00008","article-title":"A randomized controlled trial of pemoline for attention-deficit\/hyperactivity disorder in substance-abusing adolescents","volume":"43","author":"Riggs","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0193-953X(03)00089-3","article-title":"Psychosocial treatments for adults with attention-deficit\/hyperactivity disorder","volume":"27","author":"Safren","year":"2004","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","article-title":"Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence","volume":"10","author":"Schubiner","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4088\/JCP.v61n0402","article-title":"Prevalence of attention-deficit\/hyperactivity disorder and conduct disorder among substance abusers","volume":"61","author":"Schubiner","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","article-title":"Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence","volume":"98","author":"Shearer","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1300\/J069v23n01_07","article-title":"An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit\/hyperactivity disorder","volume":"23","author":"Somoza","year":"2004","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biopsych.2004.11.043","article-title":"A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit\/hyperactivity disorder","volume":"57","author":"Spencer","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archpsyc.58.8.775","article-title":"Efficacy of a mixed amphetamine salts compound in adults with attention-deficit\/hyperactivity disorder","volume":"58","author":"Spencer","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1176\/ajp.155.5.693","article-title":"Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder","volume":"155","author":"Spencer","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archpsyc.1995.03950180020004","article-title":"A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder","volume":"52","author":"Spencer","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1440-1614.2002.01052.x","article-title":"A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder","volume":"36","author":"Stevenson","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neubiorev.2003.08.013","article-title":"Serum and brain concentrations of methylphenidate: implications for use and abuse","volume":"27","author":"Swanson","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib50","first-page":"885","article-title":"The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder","volume":"150","author":"Ward","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib51","unstructured":"Weiss, G, Hechtman, L.T., 1986. Adult hyperactive subjects\u2019 view of their treatment in childhood and adolescence. In: Hyperactive Children Grown Up: Empirical Finding and Theoretical Considersations. New York, Guilford, p. 293."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1176\/ajp.142.5.547","article-title":"A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults","volume":"142","author":"Wender","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib53","first-page":"282","article-title":"Comparison of sustained-release and standard methylphenidate in the treatment of minimal brain dysfunction","volume":"41","author":"Whitehouse","year":"1980","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib54","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1176\/ajp.156.12.1931","article-title":"A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder","volume":"156","author":"Wilens","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib55","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00004714-199508000-00006","article-title":"Pharmacotherapy of adult attention deficit\/hyperactivity disorder: a review","volume":"15","author":"Wilens","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.07.004_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0740-5472(01)00193-3","article-title":"Dual diagnosis and successful participation of adolescents in substance abuse treatment","volume":"21","author":"Wise","year":"2001","journal-title":"J. Subst. Abuse Treat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606002778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606002778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T16:49:51Z","timestamp":1683564591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871606002778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0376871606002778"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.07.004","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}